3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Osteosarcoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Immunoblastic Lymphadenopathy
1
Carcinoma in Situ
1
Breast Neoplasms
1
Advanced Solid Tumor Cancer
1
Interventions
Doxorubicin
7
pembrolizumab
5
Radiotherapy
5
Specimen Handling
4
Radiation
4
Magnetic Resonance Spectroscopy
4
palbociclib
3
eribulin
3
Ifosfamide
3
Biopsy
3
pazopanib
2
brigimadlin
2
abemaciclib
2
Immunoglobulin G
2
zimberelimab
1
toripalimab
1
talimogene laherparepvec
1
silmitasertib
1
selinexor
1
ribociclib
1
peposertib
1
pemigatinib
1
olaratumab
1
olaparib
1
mirdametinib
1
liposomal doxorubicin
1
lenvatinib
1
enzalutamide
1
durvalumab
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
Clinical Trials, Phase II as Topic
×
1 year
×
Clear all
No trials found.